Michael Shayne Gallaway1, Eric Tai1, Elizabeth A Rohan1. 1. Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, Atlanta, Georgia.
Abstract
Background: Many people with cancer continue smoking despite evidence that it negatively effects cancer treatment, worsens chemotherapy toxicity, and increases risk for a second cancer. Aims: We examined tobacco treatment services offered to cancer patients at hospitals providing oncology services, including National Cancer Institute (NCI)-Designated Cancer Centers (NDCCs). Methods: We examined survey data of 6,400 U.S. hospitals from 2008 to 2015 to determine the manner in which tobacco treatment/cessation program services were provided among NDCCs and non-NDCC hospitals providing oncology services (HPOs). Results: From 2008 to 2015, 784 responses from NDCCs and 18,281 responses from HPOs were received. NDCCs (86%) reported significantly higher tobacco treatment/cessation programs owned by the hospital compared to HPOs (68%) (p < 0.001). Among NDCCs, there was a significant increasing trend of tobacco treatment/cessation programs reported owned by the hospital, the health system, or other contractual mechanism from 2008 to 2015 (p = 0.03). Conclusions: More than 80% of oncology providing hospitals report providing tobacco cessation programs, with higher percentages reported in NDCCs. As hospitals implement smoking cessation programs, partnerships between hospitals and cancer coalitions could help bring tobacco cessation activities to communities they both serve, and link discharged patients to these cessation resources so they can continue quit attempts that they initialised while hospitalised.
Background: Many people with cancer continue smoking despite evidence that it negatively effects cancer treatment, worsens chemotherapy toxicity, and increases risk for a second cancer. Aims: We examined tobacco treatment services offered to cancerpatients at hospitals providing oncology services, including National Cancer Institute (NCI)-Designated Cancer Centers (NDCCs). Methods: We examined survey data of 6,400 U.S. hospitals from 2008 to 2015 to determine the manner in which tobacco treatment/cessation program services were provided among NDCCs and non-NDCC hospitals providing oncology services (HPOs). Results: From 2008 to 2015, 784 responses from NDCCs and 18,281 responses from HPOs were received. NDCCs (86%) reported significantly higher tobacco treatment/cessation programs owned by the hospital compared to HPOs (68%) (p < 0.001). Among NDCCs, there was a significant increasing trend of tobacco treatment/cessation programs reported owned by the hospital, the health system, or other contractual mechanism from 2008 to 2015 (p = 0.03). Conclusions: More than 80% of oncology providing hospitals report providing tobacco cessation programs, with higher percentages reported in NDCCs. As hospitals implement smoking cessation programs, partnerships between hospitals and cancer coalitions could help bring tobacco cessation activities to communities they both serve, and link discharged patients to these cessation resources so they can continue quit attempts that they initialised while hospitalised.
Authors: J P Mackenbach; G J Borsboom; W J Nusselder; C W Looman; C T Schrijvers Journal: J Epidemiol Community Health Date: 2001-09 Impact factor: 3.710
Authors: Fadlo R Khuri; J Jack Lee; Scott M Lippman; Edward S Kim; Jay S Cooper; Steven E Benner; Rodger Winn; Thomas F Pajak; Brendell Williams; George Shenouda; Ian Hodson; Karen Fu; Dong M Shin; Everett E Vokes; Lei Feng; Helmuth Goepfert; Waun Ki Hong Journal: J Natl Cancer Inst Date: 2006-04-05 Impact factor: 13.506
Authors: Ellen R Gritz; Michelle Cororve Fingeret; Damon J Vidrine; Amy B Lazev; Netri V Mehta; Gregory P Reece Journal: Cancer Date: 2006-01-01 Impact factor: 6.860
Authors: Kim-Anh Do; Marcella M Johnson; Dorota A Doherty; J Jack Lee; Xi Feng Wu; Qiong Dong; Waun K Hong; Fadlo R Khuri; Karen K Fu; Margaret R Spitz Journal: Cancer Causes Control Date: 2003-03 Impact factor: 2.506
Authors: Karen Emmons; Frederick P Li; John Whitton; Ann C Mertens; Raymond Hutchinson; Lisa Diller; Leslie L Robison Journal: J Clin Oncol Date: 2002-03-15 Impact factor: 50.717